Cardiovascular Disease Doctors in Tempe, AZ Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Dr. M. Jamil Akhtar, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2157 E Baseline Rd, Suite 101, Tempe, AZ 85283 Phone: 480-962-9494    Fax: 480-962-8140

Ghassan Fraij, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1847 E Southern Ave Ste 4, Tempe, AZ 85282 Phone: 480-878-4077    Fax: 480-489-5269

Dr. Jagwinder S Sraow, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 E Southern Ave, Suite I-1, Tempe, AZ 85282 Phone: 480-821-3800    Fax: 480-821-3806

Dr. Cristina Pecci, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1492 S Mill Ave Ste 113, Tempe, AZ 85281 Phone: 602-234-0004

Dr. Umaima Fatima, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2157 E Baseline Rd, Suite 101, Tempe, AZ 85283 Phone: 480-962-9494    Fax: 480-962-8140

News Archive

CRF initiates Harmonizing Outcomes with Revascularization and Stents in AMI II trial

The Cardiovascular Research Foundation (CRF) today announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-chromium everolimus-eluting stents versus Omega bare-metal stents in patients with heart attack undergoing primary angioplasty with bivalirudin anticoagulation.

Shrinking in hippocampus area of brain precedes Alzheimer's disease

People who have lost brain cells in the hippocampus area of the brain are more likely to develop dementia, according to a study published in the March 17, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.

Scientists reveal novel drug delivery approach to fight swine flu at gene level

Scientists from Tomsk Polytechnic University together with their colleagues from St. Petersburg and London have elaborated a new approach to deliver anti-viral RNAi to target cells against H1N1 influenza virus infection.

FDA clears Neurelis IND to commence NRL-1 clinical trials for acute breakthrough seizures

Neurelis, Inc. today announced that the United States Food and Drug Administration (FDA) has cleared an Investigational New Drug application (IND) to commence clinical trials advancing the development of NRL-1 for the treatment of acute breakthrough seizures.

CRD to conduct review of safety and effectiveness of BMP-2

The Centre for Reviews and Dissemination (CRD) at the University of York is to conduct a major independent review of the effectiveness and safety of bone morphogenetic protein-2 (BMP-2), a product used in spinal surgeries to promote bone growth.

Read more Medical News

› Verified 3 days ago